ASSERTIO THERAPEUTICS, INC. Net Cash Provided by (Used in) Continuing Operations
ASSERTIO THERAPEUTICS, INC. reported Net Cash Provided by (Used in) Continuing Operations of $70.10 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-10.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInContinuingOperations · last filed 2017-05-10
- ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) continuing operations for the quarter ending 2017-03-31 was $70.10M, a 13.34% decline year-over-year.
- ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) continuing operations for the quarter ending 2016-12-31 was $27.35M.
- ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) continuing operations for the quarter ending 2016-09-30 was $2.54M, a 81.08% decline year-over-year.
- ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) continuing operations for the quarter ending 2016-06-30 was -$94.15M, a 327.91% decline year-over-year.
- ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) continuing operations for fiscal 2016 was $16.63M.
- ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) continuing operations for fiscal 2015 was -$387.58M, a 258.85% decline from fiscal 2014.
- ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) continuing operations for fiscal 2014 was $243.99M, a 13.17% increase from fiscal 2013.
- ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) continuing operations for fiscal 2013 was $215.60M, a 4183.69% increase from fiscal 2012.
| Period end | Net Cash Provided by (Used in) Continuing Operations 3 month | Net Cash Provided by (Used in) Continuing Operations 6 month | Net Cash Provided by (Used in) Continuing Operations 9 month | Net Cash Provided by (Used in) Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-03-31 | $70.10M 10-Q · filed 2017-05-10 | $97.45M derived: sum of 2 quarters · filed 2017-05-10 | $99.99M derived: sum of 3 quarters · filed 2017-05-10 | $5.84M derived: sum of 4 quarters · filed 2017-05-10 |
| 2016-12-31 | $27.35M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $29.89M derived: sum of 2 quarters · filed 2017-02-24 | -$64.26M derived: sum of 3 quarters · filed 2017-02-24 | $16.63M 10-K · filed 2017-02-24 |
| 2016-09-30 | $2.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$91.62M derived: sum of 2 quarters · filed 2016-11-07 | -$10.73M 10-Q · filed 2016-11-07 | -$17.14M derived: sum of 4 quarters · filed 2017-05-10 |
| 2016-06-30 | -$94.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$13.26M 10-Q · filed 2016-08-03 | -$19.68M derived: sum of 3 quarters · filed 2017-05-10 | -$6.27M derived: sum of 4 quarters · filed 2017-05-10 |
| 2016-03-31 | $80.89M 10-Q · filed 2017-05-10 | $74.47M derived: sum of 2 quarters · filed 2017-05-10 | $87.88M derived: sum of 3 quarters · filed 2017-05-10 | $129.19M derived: sum of 4 quarters · filed 2017-05-10 |
| 2015-12-31 | -$6.42M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $6.99M derived: sum of 2 quarters · filed 2017-02-24 | $48.30M derived: sum of 3 quarters · filed 2017-02-24 | -$387.58M 10-K · filed 2017-02-24 |
| 2015-09-30 | $13.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $54.72M derived: sum of 2 quarters · filed 2016-11-07 | -$381.17M 10-Q · filed 2016-11-07 | -$439.20M derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-06-30 | $41.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$394.57M 10-Q · filed 2016-08-03 | -$452.60M derived: sum of 3 quarters · filed 2017-02-24 | -$117.05M derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-03-31 | -$435.88M 10-Q · filed 2016-05-06 | -$493.92M derived: sum of 2 quarters · filed 2017-02-24 | -$158.36M derived: sum of 3 quarters · filed 2017-02-24 | -$142.50M derived: sum of 4 quarters · filed 2017-02-24 |
| 2014-12-31 | -$58.03M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $277.52M derived: sum of 2 quarters · filed 2017-02-24 | $293.38M derived: sum of 3 quarters · filed 2017-02-24 | $243.99M 10-K · filed 2017-02-24 |
| 2014-09-30 | $335.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $351.41M derived: sum of 2 quarters · filed 2015-11-09 | $302.02M 10-Q · filed 2015-11-09 | $482.42M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $15.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-03 | -$33.53M 10-Q · filed 2015-08-03 | $146.86M derived: sum of 3 quarters · filed 2016-02-26 | $166.21M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | -$49.39M 10-Q · filed 2015-05-11 | $131.00M derived: sum of 2 quarters · filed 2016-02-26 | $150.35M derived: sum of 3 quarters · filed 2016-02-26 | $173.36M derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $180.39M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $199.74M derived: sum of 2 quarters · filed 2016-02-26 | $222.74M derived: sum of 3 quarters · filed 2016-02-26 | $215.60M 10-K · filed 2016-02-26 |
| 2013-09-30 | $19.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $42.35M derived: sum of 2 quarters · filed 2014-11-06 | $35.21M 10-Q · filed 2014-11-06 | $36.91M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | $23.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | $15.86M 10-Q · filed 2014-08-06 | $17.56M derived: sum of 3 quarters · filed 2015-02-26 | $31.41M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | -$7.15M 10-Q · filed 2014-05-09 | -$5.44M derived: sum of 2 quarters · filed 2015-02-26 | $8.41M derived: sum of 3 quarters · filed 2015-02-26 | |
| 2012-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $15.55M derived: sum of 2 quarters · filed 2015-02-26 | $5.03M 10-K · filed 2015-02-26 | |
| 2012-09-30 | $13.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $3.33M 10-Q · filed 2013-11-07 | ||
| 2012-06-30 | -$10.52M 10-Q · filed 2013-08-08 | |||
| 2011-12-31 | $1.52M 10-K · filed 2014-03-17 |